OH-based Redi Health secures $14million in series B round funding. Leading the round was Blue Heron Capital, with participation from M25, Mutual Capital Partners, Rev1 Ventures, and Refinery Ventures—all inside investors.
Jim Clair, a member of the Blue Heron OA Collaborative, joined Redi’s board of directors concurrently with the funding. The company intends to use the money to speed expansion, promote innovation, create and introduce new products, and broaden its patient base.
Read also – CA-based Trianz Secures a Major Growth Equity Investment
Redi Health, under the direction of co-founder and CEO Luke Buchanan, provides patients with chronic diseases with digital support to help them understand, manage, and track their overall health.
Their web and mobile platforms offer a smooth patient experience by combining pharmaceutical manufacturer support with health management technologies.
About Redi Health
Redi Health was established in 2021 with the straightforward objective of enabling individuals to take charge of and participate in their own health journeys. They think that when it comes to medical care, the patient is frequently overlooked and is forced to make their own way through the confusing world of medicine.
Redi.Health was created in order to address this issue. Redi offers patients easier-to-use tools than ever before and develops new channels for connecting them to services and support that they might not otherwise have access to.
Read also – PA-based Abridge Secures an Additional $150Million Funding
